Esperion Therapeutics Inc.

Esperion Therapeutics Inc.

ESPR

Market Cap$215.98M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Esperion Therapeutics Inc.Esperion Therapeutics Inc.-4-22%0.9-0.8
$11.14

Current Fair Value

1178.7% upside

Undervalued by 1178.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$215.98 Million
Enterprise Value$377.34 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.28
Beta0.86
Outstanding Shares191,056,343

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-4.02
PEG14.16
Price to Sales0.87
Price to Book Ratio-0.29
Enterprise Value to Revenue1.28
Enterprise Value to EBIT22.99
Enterprise Value to Net Income-5
Total Debt to Enterprise0.81
Debt to Equity-0.79

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Esperion Therapeutics Inc.

CEO: Timothy Mayleben